Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2010 Mar 12;393(3):420-5. doi: 10.1016/j.bbrc.2010.02.010. Epub 2010 Feb 6.

SOX2 modulates alternative splicing in transitional cell carcinoma.

Author information

1
Department of Pathology, Chia-Yi Christian Hospital, Chiayi, Taiwan.

Abstract

Aberrant alternative splicing of key cellular regulators may play a pivotal role in cancer development. To investigate the potential influence of altered alternative splicing on the development of transitional cell carcinoma (TCC), splicing activity in the TCC cell lines TSGH8301 and BFTC905 was examined using the SV40-immortalized uroepithelial cell line SV-HUC-1 as a reference. Our results indicate a significant alteration in splice site selection in the TCC cell lines. By gene expression profiling and subsequent validation, we discovered that sex-determining region Y-box protein 2 (SOX2) is specifically upregulated in BFTC905. Furthermore, ectopic expression of SOX2 modulates alternative splicing of the splicing reporter in vivo. More significantly, using an in vitro pull-down assay, it was found that SOX2 exhibits RNA-binding capability. Our observations suggest that SOX2 modulates alternative splicing by functioning as a splicing factor.

PMID:
20138825
DOI:
10.1016/j.bbrc.2010.02.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center